公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 QIAGEN BIOTECNOLOGIA BRASIL LTDA.取消

74 记录

产品持有公司班级有效性
artus CT/NG QS RGQ Kit10322250075QIAGEN BIOTECNOLOGIA BRASIL LTDA.III20/02/2027
QuantiFERON Monitor Tubos10322250076QIAGEN BIOTECNOLOGIA BRASIL LTDA.I现有
QuantiFERON Monitor ELisa10322250078QIAGEN BIOTECNOLOGIA BRASIL LTDA.II现有
QuantiFERON Monitor LyoSphere10322250079QIAGEN BIOTECNOLOGIA BRASIL LTDA.II现有
artus HSV 1/2 QS RGQ10322250080QIAGEN BIOTECNOLOGIA BRASIL LTDA.III02/01/2028
QuantiFERON CMV 2 Plate Kit ELISA10322250081QIAGEN BIOTECNOLOGIA BRASIL LTDA.IV26/02/2028
Família QuantiFERON CMV10322250082QIAGEN BIOTECNOLOGIA BRASIL LTDA.I现有
artus CMV QS-RGQ kit10322250084QIAGEN BIOTECNOLOGIA BRASIL LTDA.IV04/06/2028
QIAamp DSP Circulating NA Kit10322250085QIAGEN BIOTECNOLOGIA BRASIL LTDA.I现有
QIAsymphony DSP Circulating DNA Kit10322250086QIAGEN BIOTECNOLOGIA BRASIL LTDA.I现有
EZ1 DSP Virus10322250087QIAGEN BIOTECNOLOGIA BRASIL LTDA.I现有
RNeasy DSP FFPE Kit10322250088QIAGEN BIOTECNOLOGIA BRASIL LTDA.I现有
EZ1 DSP DNA Blood Kit10322250089QIAGEN BIOTECNOLOGIA BRASIL LTDA.I现有
EZ1 Advanced XL10322250090QIAGEN BIOTECNOLOGIA BRASIL LTDA.I现有
FAMÍLIA QIASTAT ANALYZER10322250093QIAGEN BIOTECNOLOGIA BRASIL LTDA.II现有
ipsogen BCR-ABL1 Mbcr RGQ RT-PCR Kit10322250096QIAGEN BIOTECNOLOGIA BRASIL LTDA.III15/06/2030
QIAStat-Dx Respiratory SARS-CoV-2 Panel10322250097QIAGEN BIOTECNOLOGIA BRASIL LTDA.III25/06/2030
therascreen PIK3CA RGQ PCR Kit10322250098QIAGEN BIOTECNOLOGIA BRASIL LTDA.III30/11/2030
ipsogen JAK2 RGQ PCR Kit10322250099QIAGEN BIOTECNOLOGIA BRASIL LTDA.III14/12/2030
PAXgene Blood RNA Kit10322250115QIAGEN BIOTECNOLOGIA BRASIL LTDA.I现有
ipsogen® CALR RGQ PCR Kit10322250120QIAGEN BIOTECNOLOGIA BRASIL LTDA.III08/05/2033
QIAstat-Dx® Meningitis/Encephalitis10322250121QIAGEN BIOTECNOLOGIA BRASIL LTDA.III15/05/2033
EZ2 Connect MDx10322250122QIAGEN BIOTECNOLOGIA BRASIL LTDA.I现有
QIAstat-Dx® Gastrointestinal Panel 210322250123QIAGEN BIOTECNOLOGIA BRASIL LTDA.III26/06/2033
Rotor-Gene Q MDx 6plex10322250127QIAGEN BIOTECNOLOGIA BRASIL LTDA.II现有

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家